TuisBNTX • NASDAQ
add
BioNTech SE - ADR
Vorige sluiting
$90,10
Dagwisseling
$89,60 - $91,60
Jaarwisseling
$79,52 - $123,98
Markkapitalisasie
24,02 mjd USD
Gemiddelde volume
1,26 m
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
NASDAQ
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (EUR) | Des. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 907,40 m | -23,75% |
Bedryfskoste | 907,20 m | 15,13% |
Netto inkomste | -305,00 m | -217,53% |
Netto winsgrens | -33,61 | -254,10% |
Wins per aandeel | -0,33 | -130,56% |
EBITDA | -266,95 m | -195,92% |
Effektiewe belastingkoers | -34,12% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (EUR) | Des. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 13,74 mjd | -13,28% |
Totale bates | 21,99 mjd | -2,40% |
Totale aanspreeklikheid | 2,76 mjd | -11,36% |
Totale ekwiteit | 19,22 mjd | — |
Uitstaande aandele | 239,97 m | — |
Prys om te bespreek | 1,18 | — |
Opbrengs op bates | -3,49% | — |
Opbrengs op kapitaal | -3,96% | — |
Kontantvloei
Netto kontantverandering
| (EUR) | Des. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | -305,00 m | -217,53% |
Kontant van bedrywe | 309,50 m | 166,80% |
Kontant van beleggings | -2,73 mjd | -549,25% |
Kontant van finansiering | -14,30 m | -95,89% |
Netto kontantverandering | -2,42 mjd | -1 860,74% |
Beskikbare kontantvloei | -1,44 mjd | -27,63% |
Meer oor
BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
The company utilizes technology platforms including mRNA-based therapies, targeted therapies, and immunomodulators, to develop its treatments. BioNTech's pipeline includes several late-stage programs in oncology testing combination therapy approaches to improve treatment outcomes.
In the field of infectious diseases, BioNTech, partnering with Pfizer, developed Comirnaty, the first approved mRNA-based vaccine, which was widely used during the COVID-19 pandemic. Wikipedia
HUB
Gestig
2008
Webwerf
Werknemers
7 807
